.
MergerLinks Header Logo

New Deal


Announced

Cresco Labs to acquire Columbia Care from Canaccord Genuity for $2bn.

Financials

Edit Data
Transaction Value£1,514m
Consideration TypeOrdinary Shares
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium16%
One Off Charge-

Tags

Edit

Public

Single Bidder

Acquisition

Domestic

cannabis company

Friendly

Majority

Pharmaceuticals

Pending

United States

Synopsis

Edit

Cresco Labs, a vertically integrated multistate cannabis operator, agreed to acquire Columbia Care, a cultivator, manufacturer and provider of cannabis products, from Canaccord Genuity for $2bn. "We are incredibly excited to announce this transformative transaction today at a very important time in the development of this industry. This acquisition brings together two of the leading operators in the industry, pairing a leading footprint with proven operational, brand and competitive excellence. The combination is highly complementary and provides unmatched scale, depth, diversification and long-term growth. On a pro-forma basis, the combined Company will be the largest cannabis company by revenue, the number one wholesaler of branded cannabis products, and the largest nationwide retail footprint outside of Florida," Charles Bachtell, Cresco Labs CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US